These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

514 related items for PubMed ID: 15559524

  • 21. [Aldosterone antagonists for all patients with heart failure?].
    Bauersachs J.
    MMW Fortschr Med; 2009 Apr 09; 151(15):33-5. PubMed ID: 19728679
    [No Abstract] [Full Text] [Related]

  • 22. Eplerenone: new drug. Recent myocardial infarction with heart failure: a spironolactone me too.
    Prescrire Int; 2006 Apr 09; 15(82):46-9. PubMed ID: 16604728
    [Abstract] [Full Text] [Related]

  • 23. [ACE inhibitors, beta blockers, AT-1 antagonists in heart failure. Right dosage and combination].
    Fliri M.
    MMW Fortschr Med; 2002 Nov 28; 144(48):38-43. PubMed ID: 12532542
    [Abstract] [Full Text] [Related]

  • 24. [Heart failure after myocardial infarction. Increased risk, poorer treatment].
    MMW Fortschr Med; 2005 Dec 01; 147(48):67. PubMed ID: 16389866
    [No Abstract] [Full Text] [Related]

  • 25. Treatment of heart failure with ACE inhibitors and beta-blockers: what is next? Aldosterone receptor antagonists?
    van der Horst IC, Voors AA, van Veldhuisen DJ.
    Clin Res Cardiol; 2007 Apr 01; 96(4):193-5. PubMed ID: 17294352
    [No Abstract] [Full Text] [Related]

  • 26. Heart failure: Part II.
    Wilkes MS, Middlekauff H, Hoffman JR.
    West J Med; 1999 Jun 01; 170(6):339-42. PubMed ID: 10443162
    [No Abstract] [Full Text] [Related]

  • 27. Aldosterone antagonism and congestive heart failure: a new look at an old therapy.
    Thohan V, Torre-Amione G, Koerner MM.
    Curr Opin Cardiol; 2004 Jul 01; 19(4):301-8. PubMed ID: 15218387
    [Abstract] [Full Text] [Related]

  • 28. Two better than one.
    SoRelle R.
    Circulation; 2003 Oct 14; 108(15):e9042-3. PubMed ID: 14557352
    [No Abstract] [Full Text] [Related]

  • 29. Update on aldosterone antagonists use in heart failure with reduced left ventricular ejection fraction. Heart Failure Society of America Guidelines Committee.
    Butler J, Ezekowitz JA, Collins SP, Givertz MM, Teerlink JR, Walsh MN, Albert NM, Westlake Canary CA, Carson PE, Colvin-Adams M, Fang JC, Hernandez AF, Hershberger RE, Katz SD, Rogers JG, Spertus JA, Stevenson WG, Sweitzer NK, Tang WH, Stough WG, Starling RC.
    J Card Fail; 2012 Apr 14; 18(4):265-81. PubMed ID: 22464767
    [Abstract] [Full Text] [Related]

  • 30. Use of spironolactone in heart failure patients receiving angiotensin-converting enzyme inhibitors and beta-blockers.
    Ahmed A.
    J Am Coll Cardiol; 2003 May 21; 41(10):1851-2. PubMed ID: 12767683
    [No Abstract] [Full Text] [Related]

  • 31. [Spironolactone in heart failure].
    López Herrero F, Pardo Alvarez J.
    Aten Primaria; 2000 Mar 15; 25(4):281. PubMed ID: 10795445
    [No Abstract] [Full Text] [Related]

  • 32. Cost-effectiveness analysis of aldosterone blockade with eplerenone in patients with heart failure after acute myocardial infarction in the French context: the EPHESUS study.
    de Pouvourville G, Solesse A, Beillat M.
    Arch Cardiovasc Dis; 2008 Sep 15; 101(9):515-21. PubMed ID: 19041835
    [Abstract] [Full Text] [Related]

  • 33. Aldosterone receptor antagonists induce favorable cardiac remodeling in diastolic heart failure patients.
    Orea-Tejeda A, Colín-Ramírez E, Castillo-Martínez L, Asensio-Lafuente E, Corzo-León D, González-Toledo R, Rebollar-González V, Narváez-David R, Dorantes-García J.
    Rev Invest Clin; 2007 Sep 15; 59(2):103-7. PubMed ID: 17633796
    [Abstract] [Full Text] [Related]

  • 34. [Efficient improvement of prognosis after myocardial infarct? Additional aldosterone inhibition is required].
    MMW Fortschr Med; 2005 Dec 01; 147(48):66-7. PubMed ID: 16392155
    [No Abstract] [Full Text] [Related]

  • 35. [Decrease in mortality on spironolactone being added to the conventional treatment of heart failure].
    Soto Alvarez J.
    Aten Primaria; 2000 Mar 15; 25(4):282-4. PubMed ID: 10795447
    [No Abstract] [Full Text] [Related]

  • 36. Eplerenone in the treatment of chronic heart failure.
    Krum H, Liew D.
    Expert Rev Cardiovasc Ther; 2004 May 15; 2(3):315-20. PubMed ID: 15151479
    [Abstract] [Full Text] [Related]

  • 37. [REMINDER Study: myocardial infarct without heart failure: does eplerenone have an advantage?].
    Overbeck P.
    MMW Fortschr Med; 2013 Mar 28; 155 Spec No 1(1):20. PubMed ID: 24260911
    [No Abstract] [Full Text] [Related]

  • 38. Spironolactone in heart failure--a revived role for an old drug.
    Bradley C.
    Intensive Crit Care Nurs; 2000 Dec 28; 16(6):403-4. PubMed ID: 11091472
    [Abstract] [Full Text] [Related]

  • 39. Heart failure after acute ST-segment elevation myocardial infarction: what should we do about it?
    Conti CR.
    Clin Cardiol; 2005 Aug 28; 28(8):360-1. PubMed ID: 16144210
    [No Abstract] [Full Text] [Related]

  • 40. [Medical treatment of chronic heart failure].
    Schüpfer CA.
    Praxis (Bern 1994); 2007 Mar 14; 96(11):405-10. PubMed ID: 17405532
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 26.